Introduction b-N-acetylhexosaminidases (EC 3.2.1.52, HEX) hydrolyze the terminal b-D-GlcNAc and b-D-GalNAc residues of oligosaccharide chains [1] . These enzymes have primarily been studied in bacteria [2, 3] to understand their roles in cell-wall recycling. In humans, specific mutations in HEX are linked to defects in degradation of GM2 ganglioside, which leads to neuronal dysfunction and early death (Tay-Sachs and Sandhoff diseases) [4] . Ongoing interest in these enzymes is fueled by additional recently discovered biological functions, including their roles in seed germination and vegetable ripening [5, 6] , turnover of the chitin exoskeleton in insects [7] , mammalian fertilization [8, 9] , and bacterial resistance to b-lactam antibiotics (products of b-N-acetylglucosaminidases induce expression of b-lactamase) [10] . In fungi, HEX are important components of the binary chitinolytic system implicated in degradation of chitooligomers and chitobiose required for fungal cell-wall regeneration and hyphae formation [11, 12] .
HEX have also attracted considerable attention due to their applications in carbohydrate biotechnology. They are used in synthesis of new oligosaccharides by means of transglycosylation reactions in which a carbohydrate moiety is transferred from an activated saccharide donor to its acceptor, typically an alcohol or a carbohydrate. This provides a good alternative to glycosyltransferases due to the high regioselectivity and relatively inexpensive substrates [13] . Moreover, HEX have shown broad substrate specificity, tolerating a variety of unnatural substrates including carboxylates, sulfates, acyls, azides, and 4-deoxyglycosides [1] . In particular, HEX orthologs of GH families 20 or 84 obtained from filamentous fungi, mainly from Aspergillus, Penicillium, and Talaromyces genera, proved efficient in such synthetic reactions, making fungal HEX versatile tools for preparation of novel oligosaccharides [1, [13] [14] [15] .
HEX from Aspergillus oryzae (AoHEX) belongs to the GH 20 glycoside hydrolase family [16] . Although all members of this glycoside hydrolase branch share certain structural features (such as a TIM barrel) and the same substrate-assisted catalytic mechanism [1, 17, 18] , fungal members of the GH 20 family have an unusual molecular architecture. These extracellular enzymes form dimers that consist of two monomeric N-glycosylated catalytic domains (each of approximately 65 kDa) that are noncovalently associated with two large O-glycosylated propeptides (each having at least 76 amino acids and a molecular mass of approximately 10 kDa) [16, 19, 20] . The propeptide plays a unique role in enzyme regulation. When only a single propeptide molecule is associated with the dimer of the catalytic core, the enzyme complex shows approximately 50% specific activity [19] . The propeptide, which is conserved across the entire fungal HEX subfamily, is cleaved in the endoplasmic reticulum and immediately reassociates with the catalytic core [19] . The fungus uses the propeptide as an enzymatic regulator to control HEX activity at various stages of its growth cycle [19] . A similar function has been described for other Class I propeptides that catalyze the correct folding of proteins [21, 22] . Although most of these Class I propeptides, also described as intramolecular chaperones, are cleaved after protein activation, some propeptides stabilize the resulting protein structure [21, 22] . From this perspective, fungal hexosaminidases from the GH 20 family are unique because their propeptides stabilize the protein using noncovalent interactions [19] .
To date, the majority of reported crystal structures of HEX from the GH 20 structural family are of bacterial origin, in particular from Streptomyces, Streptococcus, Serratia, and Paenibacillus species (reviewed in Ref. [23] ). In addition, the structures of the a and b chains of human hexosaminidases A and B have been determined [24] [25] [26] [27] . More importantly, the chitinolytic hexosaminidase from the Asian corn borer moth (Ostrinia furnacalis) has been intensively studied as a potential target for insecticides [28, 29] , and its structure was identified as a useful template for modeling of fungal hexosaminidases because it is the genetically closest homolog of AoHEX [16, 30] . In the absence of an experimentally determined AoHEX structure, a homology modeling approach was used previously to model AoHEX [31] and other fungal HEX [14, 32] .
Here, we report the crystal structure of AoHEX from A. oryzae CCF1066, analyze its glycosylation, and describe validation of the propeptide-catalytic unit interactions in solution using protein cross-linking and mass spectrometry. Our results improve understanding of the unique catalytic properties of fungal hexosaminidases and explain the molecular mechanism for enzyme activation by stabilization of the catalytic core by noncovalently associated chain-swapped propeptide.
Results

Crystal structure of AoHEX
The crystal structure of AoHEX isolated from its natural source was solved by single anomalous dispersion (SAD; Table 1 ). The primitive tetragonal crystal contained 60% solvent and two protein molecules in the asymmetric unit. Residues 19-90 and 103-599 of monomer A and residues 19-91 and 103-600 of monomer B were modeled into the electron density map, corresponding to chains A, B, C, and D, respectively, in the crystallographic model submitted to the PDB database under the accession number 5OAR. Terminal residues 91-96, 102, and 600 of monomer A and 92-96 and 102 of monomer B are missing in the crystallographic model. Nonprotein electron density was explained by 2 N-acetylglucosamine thiazoline (NGT) molecules, 16 sugar moieties, 177 water molecules, 11 chloride anions, and 1 hexatantalum tetradecabromide cluster soaked into the crystal for phasing. The RMSD for superposition of the 569 Ca atoms of the two protein monomers in the asymmetric unit was 0.279 A, a typical value for independently solved structures of identical proteins [33] . Monomer A provided a better resolved electron density map, lower overall B factor, and higher ligand occupancy (see Table 1 ) and was therefore used for further detailed structural description.
The two molecules in the asymmetric unit represent one biological unit-a dimer composed of two catalytic cores (residues 102-600) and two noncovalently attached propeptides (residues 19-96; see Fig. 1 ). Residues 1-18 correspond to a prepropeptide signal sequence that is cleaved during excretion and is not present in the mature protein. Each AoHEX monomer consists of a catalytic core noncovalently associated with the N-terminal propeptide sequence. The propeptide is cleaved by dibasic processing peptidase in the endoplasmic reticulum [19] . During this activation, residues 97-101 (sequence KKSKR) are excised. The propeptide remains tightly associated with the AoHEX core, and 61 of its 72 modeled residues interact with 87 residues of the enzyme's core, forming a substantial interface area of 3065.5 A , as determined by Protein Interfaces, Surfaces, and Assemblies (PISA) [36] . Upon cleavage, the propeptide obviously undergoes a structural change, as the released C-terminus extends toward the catalytic core of the second dimer subunit (the distance between the C-terminal propeptide Statistics for the highest resolution shell are in parentheses.
, where I i (hkl) is the individual intensity of the ith observation of reflection hkl and ‹I(hkl)› is the average intensity of reflection hkl with summation over all data. The multiplicity-corrected version of R merge . c Pearson's correlation coefficient determined on the dataset randomly split in half.
where F o and F c are the observed and calculated structure factors, respectively. e R-free is equivalent to R value but is calculated for 5% of the reflections chosen at random and omitted from the refinement process [34] .
f As determined by Molprobity server [35] .
residue T90 and the N-terminal core residue S103 is more than 50 A, Fig. 1A , B). The AoHEX core comprises two subdomains: a central (b,a) 8 -barrel subdomain and an N-terminal a/bsubdomain. As also suggested by a previous study [37] using mass spectrometry analysis, the three-dimensional structure is stabilized by three disulfide bridges: C 290 -C 351 , C 448 -C 483 , and C 583 -C 590 . The active site of the enzyme is located in the central (b,a) 8 -barrel and occupied by the inhibitor NGT, which is a reaction intermediate analog. The refined 2F o ÀF c electron density map for the inhibitor is shown in Fig. 1D . The inhibitor forms numerous polar interactions with AoHEX, in particular hydrogen bonds with residues R193, D447, W482, E519, and with residue D345 from the catalytic dyad (D345-E346) and a sulfur-centered hydrogen bond with residue Y445. A structurally important water molecule (W819) provides additional water-mediated hydrogen bonding of the inhibitor with residues D222, D271, H275, and D345 (Fig. 1C) .
Analysis of AoHEX glycosylation in the crystal structure
The crystallized protein originated from its natural source (A. oryzae) and thus contained its native glycosylation pattern. N-glycosylation of the catalytic core had been characterized previously by mass spectrometry analysis. Specifically, six asparagine residues in the AoHEX core were identified as possible Nglycosylation sites based on the protein sequence [16] . In our crystal structure, we observed electron density indicating the presence of glycans attached to five asparagine residues ( Table 2 ). The quality of the electron density allowed us to partially model the following attached glycans for the following residues: Man-b (1?4)GlcNAc-b(1?4)GlcNAc-b-N353, GlcNAc-b(1? 4)GlcNAc-b-N428, and GlcNAc-b-N500. However, we were unable to model the glycans attached to residues N318 and N387. We did not observe any electron density indicating glycosylation of residue N525. Moreover, the N525 side chain is buried at the dimer interface and engaged in hydrogen bonding. To resolve the discrepancy between our finding and the literature [16, 31] , we analyzed the enzyme preparation used for X-ray crystallography by high-resolution mass spectrometry. Modifications of asparagine residues 318, 353, 387, 428, and 500 by heterogeneous high-mannose oligosaccharides were detected, while no modification was observed for N525. The microheterogeneity of the individual glycan chains is shown in Table S1 .
The propeptide of AoHEX is O-glycosylated. Electron density that could be explained by attached a-Omannose was detected for residues T78, S83, and S84 (Table 2 ). Propeptide glycosylation was further investigated by MS analysis. 
Mass spectrometric analysis of propeptide glycosylation
Mass spectrometric analysis of the isolated AoHEX propeptide was used to characterize site-specific glycoforms and microheterogeneity in detail. In particular, data reported previously [16] were extended and supported by high-resolution mass spectrometry measurements. The AoHEX propeptide was previously shown to be O-glycosylated in its C-terminal portion [16] . Our data confirmed the presence of a hexose (Hex) ladder, with between 4 and 11 Hex additions across the entire (uncleaved) propeptide ( Fig. 2A) . Species with seven or eight Hex were more abundant. Assignment of the exact positions of the glycans along the propeptide sequence remained challenging, considering the presence of three serine and three threonine residues in its C-terminal segment. Using a combination of collision-induced dissociation (CID, Fig. 2B ) and electron capture dissociation (ECD, Fig. 2C ), we recorded a high-quality sequence of fragments of the entire propeptide, including c5, c7, c9, c10, c11, c12, and up to c59, none of which contained any Hex addition. The occurrence of fragments c60+Hex and c61+Hex clearly indicated T78 as the first substituted amino acid (the first 18 residues are a prepropeptide not present in the mature enzyme; see Fig. 2C ). In addition, the presence of c65 fragment ions with one and two Hex in ECD spectra pointed to glycosylation of S83 (Fig. 2C) . The CID spectra revealed a series of y-ions. In contrast to the y8 and y10 ions, the y6 ion was observed without any modification, demonstrating the presence of a glycan moiety on T90. Thus, we conclude that T92 and S96 are not modified (Fig. 2B) .
Analysis of the dimer interface in the crystal structure
The AoHEX crystal structure contains one dimer in the asymmetric unit. The dimer interface, formed by 112 residues of monomer A and 113 residues of monomer B, has an area of 4302.8 A 2 and is stabilized by 56 hydrogen bonds and 10 salt bridges. The solvation free energy gain upon formation of the interface is À51 kcalÁmol
À1
. These observations confirm that this dimeric assembly represents the biologically active unit of the enzyme, which is in agreement with previously reported size-exclusion chromatography analysis [19] .
The propeptide contributes significantly to the formation of the dimer interface (see Fig. 3 ). The interaction of seven residues of propeptide A with nine residues of core B accounts for an area of 336 A 2 (13% of the total interface area) and a solvation free energy gain of À7.2 kcalÁmol À1 (7% of the total solvation free energy gain, as calculated by the PISA server [36] ). A list of the propeptide A residues and core A and core B residues within the mutual van der Waals distance (up to 4.2 A) is shown in Table S2 .
Interestingly, the AoHEX dimerization interface also involves glycan components. Three sugar moieties were found to be involved in dimer interface interactions (highlighted in bold in Table 2 ). Specifically, Glycosylation of S84 could not be unambiguously identified by mass spectrometry due to its location adjacent to S83 in the propeptide sequence. Residue T90 is the last modeled residue of the propeptide in monomer A, so the quality of the electron density map was too low to observe any potential glycosylation. Residue P91 is the last modeled residue of the propeptide in monomer B, so the quality of the electron density map was too low to observe any potential glycosylation at T90. e This site was reported in Refs [16, 31] .
b-GlcNAc moiety attached to core residue N500 of one monomer is within van der Waals distance from core residues 463-464 of the other monomer, b-GlcNAc moiety attached to core residue N353 of one monomer is within van der Waals distance from propeptide residues 88-89 of the other monomer, and the a-Man moiety attached to propeptide residue S83 interacts with core residues 291-292 and forms two hydrogen bonds with the side chain of D292 (see Fig. 3 ).
Analysis of the dimer interface in solution by mass spectrometry
We used AoHEX cross-linking to corroborate the crystal structure in solution and to exclude the possibility that the propeptide chain swap is a crystallization artifact. The zero-length condensation reagent 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) efficiently covalently linked the catalytic core to the propeptide (Fig. 4A) . To test whether cross-linking influenced the AoHEX structure, we determined the specific activity of EDCcross-linked AoHEX and compared it to that of the native enzyme. The enzymatic activities were comparable over most of the pH range. In an acidic environment (pH 2-3), the cross-linked AoHEX was actually more active than the native enzyme because the crosslinking prevented propeptide dissociation (Fig. 4B) . A list of the residues of propeptide A and residues of core A and core B within the mutual van der Waals distance is given in Table S2 . Detailed analysis of protein cross-links allowed us to estimate the propeptide position within the AoHEX structure. As EDC is a typical zero-length cross-linker, the assigned cross-links indicate the proximity of the N-terminal or side chain amino group with the carboxyl of acidic amino acids or the C-terminal carboxyl. The identified cross-links (Table 3 ) are in good agreement with the positions of the cross-linked residues in the AoHEX structure, as indicated by the distances between them in the crystal structure. A cross-link between propeptide residue S96 and core residue K360 confirmed that the C-terminus of the propeptide indeed interacts with the second catalytic core. In our crystal structure, residues 91-96 were not modeled due to disorder. However, the terminal modeled residue, T90, is located near K360 (distance of 14.6 A), and thus, we assume that the disordered Cterminal S96 also is in the vicinity of K360. The crosslinking analysis confirmed that the propeptide chain swap occurs in native AoHEX in solution and is not a crystallization artifact.
Discussion
The crystal structure reported here is the first experimentally determined structure of a b-N-acetylhexosaminidase originating from a fungus. The protein was isolated from its natural source and thus underwent native fungal post-translational modifications including glycosylation and propeptide cleavage. The threedimensional structure of AoHEX, solved by experimental phasing and refined using data to 2.3 A resolution, shares structural similarity with numerous hexosaminidase structures available in the Protein Data Bank (PDB). A structural similarity search using the program Dali [38] identified hexosaminidase from the agricultural insect pest Ostrinia furnacalis, further referred to as OfHEX, as the closest structural homolog of AoHEX with the sequence identity of 32%. Superposition of the AoHEX and OfHEX (PDB ID: 3OZO [28, 29] ) structures yielded an RMSD value of 1.8
A for a monomer (572 aligned residues) and 1.9 A for a dimer (971 aligned residues). The next closest structural homologs of AoHEX are human hexosaminidase B (homodimer of two chains b) and human hexosaminidase A (heterodimer of chains a and b), despite their evolutionary distance [30] . The RMSD values for superposition of AoHEX with human hexosaminidase chain b (HsHEXb, PDB ID: 1NP0 [24] ) and chain a (HsHEXa, PDB ID: 2GK1 [25] ) were 1.8 and 2.0 A, respectively. The RMSD values for superposition of the AoHEX dimer with the dimers of human hexosaminidases B and A were 1.4 A (894 aligned residues) and 1.5 A (895 aligned residues), respectively. Other structural homologs of AoHEX include hexosaminidases from bacteria such as Streptomyces coelicolor [39] , Bacteroides fragilis, Streptomyces plicatus [40] , Arthrobacter aurescens, and Paenibacillus sp. TS12 [41] ; the RMSD values for structural superposition were over 2.5
A. Prokaryotic hexosaminidases differ from AoHEX substantially in their molecular architecture, as they lack the propeptide and function in a monomeric form.
Identification of variable structural elements
Structure-based alignment performed on the Dali server [38] with the sequences of AoHEX and its closest homologs OfHEX, HsHEXb, and HsHEXa is shown in Fig. 5 . The overall molecular structure of these proteins is similar, but they differ in several structural elements: the propeptide, loops 1 and 2 surrounding the active site, and the C-terminal extension. These regions are highlighted in the sequence alignment in Fig. 5 , illustrated in Fig. 6 , and further described below for individual structural elements.
The propeptide of AoHEX (residues 19-96) is noncovalently associated with the enzyme catalytic core (Fig. 7) . The propeptide of AoHEX is 20 amino acids longer than the propeptide of HsHEXb (residues 50-107) and 27 amino acids longer than the propeptide of HsHEXa (residues 23-74). The propeptides of both HsHEXb and HsHEXa are covalently associated with the catalytic cores through disulfide bridges (C 91 -C 137 in HsHEXb and C 58 -C 104 in HsHEXa) [24, 25] . OfHEX contains a propeptide-like N-terminal part (residue 23 to approximately residue 123), which is not proteolytically processed and remains in one polypeptide chain with the OfHEX core. Residues 23-62 of OfHEX have no homology with the AoHEX structure and form an N-terminal extension unique to the OfHEX structure. The part of OfHEX that is structurally homologous to the propeptide of AoHEX (residues 63-123) is 17 residues shorter than the AoHEX propeptide [28, 29] .
Another structural element in which AoHEX differs from its homologs is loop 1 (residues 29-311). In the HsHEXa chain, this region serves as a binding site for the GM2 activator protein, allowing degradation of GM2 ganglioside [42, 43] . In the HsHEXb chain, residues 312-315 are proteolytically cleaved off. In AoHEX, loop 1 is longer and includes a short helix (HL1 in Fig. 5 ). Loop 1 of OfHEX (residues 316-332) contains a similar helix, while loop 1 in both HsHEXb (residues 309-320) [24] and HsHEXa (residues 277-288) adopts a b-turn conformation [25] (see Figs 5 and 6) . Loop 1 contains a conserved cysteine residue that forms a disulfide bond with a cysteine residue in core helix I (C 290 -C 351 in AoHEX, C 316 -C 373 in OfHEX, C 309 -C 360 in HsHEXb, and C 277 -C 328 in HsHEXa). Loop 1 of OfHEX contains an additional internal disulfide bond (C 326 -C 331 ) [24, 25, 28, 29] .
There are also striking differences in loop 2 of AoHEX and its homologs. Loop 2 contains 48 amino acids in AoHEX (residues 440-487), 26 amino acids in OfHEX (residues 470-495), and only 12 amino acids in HsHEXb (residues 447-458) and HsHEXa (residues 418-429). Loop 2 is stabilized by an internal disulfide bridge in both AoHEX (C 448 -C 483 ) and OfHEX (C 478 -C 491 ) [24, 25, 28, 29] .
Another structural feature in which AoHEX differs significantly from its homologs is the C-terminal region. The C-terminal region of AoHEX consists of 21 residues (residues 580-600), while this region is considerably shorter in its homologs: 13 residues in OfHEX (residues 582-594) [28, 29] , nine residues in HsHEXb (residues 548-556) [24] , and 11 residues in HsHEXa (residues 519-528) [25] . The longer C-terminal extensions in AoHEX and OfHEX form a short helix (CTH in Fig. 5 ) that is stabilized by an internal disulfide bridge (C 583 -C 590 in AoHEX and C 585 -C 592 in OfHEX) [24, 25, 28, 29] . In HsHEXb and HsHEXa, the shorter C-terminal extension remains in a random coil conformation (see Fig. 6 ) and is attached to core helix R through a disulfide bridge (C 534 -C 551 in HsHEXb and C 505 -C 522 in HsHEXa).
Variable structural elements shape the active pocket
The structural elements described above, together with the conserved parts of the central (b,a) 8 -barrel subdomain, are involved in the architecture of the enzyme active pocket. Differences in these structural elements affect the shape and properties of the active site and thus influence enzyme activity and specificity (see Fig. 8 ).
In AoHEX, the active pocket is shaped by structural elements from both monomers of the biologically active dimer (Fig. 8A) : loop 1 and loop 2 line the active site entrance, together with the C-terminal extension of the second monomer. In addition, the tip of loop 2 of the second monomer extends over the active site entrance. On the opposite side of the active pocket entrance, the propeptide of the second monomer supports loop 1 and the C-terminal extension of the second monomer, which form the actual active pocket. The shape of the AoHEX active pocket is therefore deeper and narrower than those of its homologs.
In OfHEX [28, 29] , the active site entrance is formed primarily by loop 1 and loop 2. Loop 2 of the second monomer does not reach the active site area, and the propeptide-like sequence from the second monomer comes in contact only with the C-terminal extension of the second monomer, but not with loop 1 as observed in AoHEX. The active pocket of OfHEX is relatively deep, but unlike the AoHEX pocket, its entrance is not obstructed by any structural element.
In contrast to AoHEX and OfHEX, the active site entrance in HsHEXb [24] and HsHEXa [25] is formed only by loop 2, with no involvement from loop 1 and the C-terminal extension. Moreover, loop 2 of the second monomer of the biologically active dimer directly contributes to the formation of the active site entrance. The propeptide is not involved in the active site architecture of any HsHEX. As a result, the active sites of HsHEXa and HsHEXb are much shallower and wider than those of AoHEX and OfHEX [28] .
Comparison of crystal structures with the active site occupied by the inhibitor NGT allows us to compare residues involved in substrate recognition and enzyme activity (see Fig. 9 ). The active pocket of HsHEXa differs from that of HsHEXb at only two residues-N423 and R424, located in loop 2 [44] ; the asparagine residue binds the inhibitor NGT (see also Fig. 5 ) [25] . These two residues are necessary for recognition of negatively charged substrates that are degraded only Residues 91-96 are not present in the crystal structure (due to disorder); distance was not measured.
c A102 is not present in the crystal structure (due to disorder); distance was measured from the N-terminal modeled residue, S103.
by HsHEXa [43] [44] [45] . Loop 2 of HsHEXb contains residues D452 and L453 at the equivalent positions. D452 is involved in polar contacts with NGT [24] .
This aspartate residue is conserved in both AoHEX (D447) and OfHEX (D477) where it also forms contacts with NGT. This aspartate residue repels and arrows (b-strands) and labeled according to HsHEX topology, as described in Ref. [26] ; secondary structure elements that differ from HsHEX are labeled in italics. Propeptides or the homologous N-terminal sequence of OfHEX are highlighted in blue, loop 1 in orange, loop 2 in red, and C-terminal extension in green with boundaries labeled for AoHEX by residue numbers. Catalytic dyad residues are highlighted in magenta, residues forming the +1 subsite are highlighted in cyan, and residues in contact with the inhibitor NGT are in boxes.
negatively charged substrate moieties the same way as in HsHEXb [25] . In contrast to human hexosaminidases, the residue adjacent to the conserved aspartate in AoHEX and OfHEX is cysteine, which is involved in the disulfide bonds stabilizing loop 2 in AoHEX (C 448 -C 483 ) and OfHEX (C 478 -C 491 ). Loop 2 directly drives the substrate specificity in human hexosaminidases A and B [25, 44] , and it likely influences the substrate specificity of AoHEX and OfHEX as well, perhaps together with the other variable structural elements that directly form the active pocket (i.e., loop 1 and the C-terminal extension). The active sites of OfHEX and AoHEX are more complex than those of human hexosaminidases (see Fig. 9 ). In OfHEX, residues V327 and E328 in loop 1 and residue W490 in loop 2 form the +1 subsite of the active pocket and are responsible for binding of the +1 saccharide moiety of the substrate [29, 46] and for the glycosidic bond specificity [46] . These residues are conserved in AoHEX (V306, E307, and W482), but absent in both HsHEXa and HsHEXb. The tryptophan residue binds the inhibitor NGT and is located next to the disulfide bond that stabilizes loop 2 in OfHEX and AoHEX. AoHEX and OfHEX can accommodate a +1 saccharide moiety in the active pocket, but the human homologs cannot and can only bind a À1 saccharide. The natural substrates of AoHEX and OfHEX are long and linear, while human hexosaminidases metabolize branched substrates with more bulky substituents [26, 28, 29] . No difference in the substrate preference of AoHEX and OfHEX has been described so far. However, 2-acetamido-1,2-dideoxy-D-gluconojirimycin, a potent inhibitor of GH20 hexosaminidases, inhibits human hexosaminidases, prokaryotic hexosaminidases, and OfHEX (K i = 3.5 lM), while it is almost inactive against AoHEX [23, 47] .
Variable structural elements contribute to dimerization
Propeptide, loop 1, loop 2, and the C-terminal extension-the structural elements in which AoHEX is distinct from its homologs-play important roles in dimerization, too. As a consequence, the dimeric interfaces of AoHEX, OfHEX, and HsHEX are significantly different (see Figs 8 and 10) .
The dimer interface of AoHEX involves the following interchain interactions between the variable structural elements (the elements of the second monomer are marked with an apostrophe): propeptide with loop 1', loop 1 with C-terminal extension', and loop 2 with loop 2' and C-terminal extension'. Interestingly, the C-terminal part of the propeptide, released upon proteolytic cleavage, extends toward the second monomer and interacts with its core in a chain swap manner. The chain swap interaction of the propeptide observed in the crystal structure was also confirmed in solution by chemical cross-linking.
The dimer interface of OfHEX consists of interchain interactions analogous to those of AoHEX, except for the propeptide contribution [28, 29] . In contrast to the substantial involvement of all the variable structural elements in the dimer contacts in AoHEX, the dimer interface includes only the interchain interaction of loop 2 with loop 2' in both human hexosaminidases A and B. The C-terminal extension of human hexosaminidases A and B also takes part in dimerization, but interacts only with the HsHEX core. Despite the relatively weaker dimer association, both human hexosaminidases A and B function as dimers in solution [24, 25] .
We have also compared the X-ray structure of AoHEX with its previously reported homology model [31] . The RMSD value for the superposition of the core domain was 2.5 A (for 325 aligned residues). The model and the X-ray structure superpose well for the conserved parts of the catalytic core, but the variable structural elements of the model differ substantially from those of the X-ray structure and the propeptide was not included in the computational model.
In conclusion, the three-dimensional structure of b-N-acetylhexosaminidase from A. oryzae reveals that this enzyme assembles into a very tight dimeric form and is further stabilized by extensive glycosylation. The active site of this fungal hexosaminidase is stabilized by dimerization of the individual catalytic cores and by the interaction of the catalytic core of one subunit in the active dimer with the propeptide of the second subunit. Stabilization of the dimer by the noncovalently associated propeptide through this chain swap explains the structural mechanism by which the enzyme is activated upon propeptide cleavage by dibasic processing peptidase in the endoplasmic reticulum. The active pocket of AoHEX is deeper than that of its homologs and is surrounded by accessory structural elements that 'gate' the entrance and restrict the size of the substrate that can be accommodated within the active site.
These structural features make AoHEX a very stable and robust framework suitable for biotechnological applications. Enzymes modifying N-acetylhexosamine substrates are gaining importance in practical applications in biology, biomedicine, and biotechnology [15] . Knowledge of three-dimensional structures is beneficial for design of engineered mutant enzyme variants with desired specificity and activity.
The structure of b-N-acetylhexosaminidase from A. oryzae reported here provides structural insights into the active pocket shape configuration. We foresee that recombinant mutated variants of this enzyme could be designed to enhance selective preparation of both natural and modified glycosidic structures that are otherwise difficult to achieve.
Materials and methods
Isolation of AoHEX
Aspergillus oryzae b-N-acetylhexosaminidase (AoHEX) was isolated from its natural source using a previously described protocol [48] . Briefly, the A. oryzae strain CCF 1066 (Czech Collection of Fungi, Department of Botany, Charles University, Prague) was grown at 28°C for 10 days in a minimal medium. The secreted native enzyme was isolated from the medium. The crude enzyme obtained by precipitation of the culture medium with ammonium sulfate was purified by three liquid chromatography steps on Phenyl-Sepharose HP, SP-Sepharose HR, and Mono Q columns. The final purification was achieved by gel filtration on a Superdex 200 HR column equilibrated in 20 mM sodium citrate, pH 5.0 buffer, containing also 0.3 M NaCl and 1 mM sodium azide. The enzymatic activity and purity of the prepared protein were monitored using the chromogenic substrate 4-nitrophenyl-2-acetamido-2-deoxyglucopyranoside [31] and by SDS/PAGE throughout the whole purification procedure. The purified enzyme (> 95% pure as judged by silver-stained SDS/ PAGE) was concentrated to 13.4 mgÁmL À1 (Bradford assay;
Bio-Rad, Hercules, CA, USA) and stored at À20°C.
Crystallization and diffraction data collection
Initial AoHEX crystallization was described previously [48] . The optimal conditions that produced well-diffracting crystals were 1 M ammonium sulfate, 20% PEG 3350, and 100 mM HEPES, pH 8.0. Hanging drops were set up by mixing 1 lL of the reservoir solution with 2 lL of AoHEX solution at 13.4 mgÁmL À1 concentration with 5 mM NGT. For phasing, the crystals were soaked with a saturated solution of hexatantalum tetradecabromide (Jena Bioscience, Jena, Germany). The crystals were frozen directly in liquid nitrogen without additional cryoprotection. Diffraction data were collected at 100 K at beamline BL14.2 of BESSY, Berlin, Germany, at a wavelength of 1.25 A [49] . Data from a crystal soaked with hexatantalum tetradecabromide for 73 h were collected at a wavelength of 1.25 A and were used for phasing; data from crystal soaked for 20 h were used for refinement. Diffraction data were processed using the HKL-3000 suite of programs [50] and XDS [51] . Crystal parameters and data collection statistics are summarized in Table 1 .
AoHEX structure determination and analyses
The AoHEX crystal structure was determined by SAD, utilizing the anomalous signal from tantalum. One hexatantalum tetradecabromide cluster site was found. All procedures for phasing and phase improvement by density modification were carried out using the HKL-3000 software package [50, 52, 53] . The initial model, containing 70% of all residues, was constructed automatically by Buccaneer [54] using electron density maps after density modification with the program [55] . Model refinement was carried out using the program REFMAC 5.7 [56] from the CCP4 package [57] , interspersed with manual adjustments using Coot [58] . The final steps included TLS refinement with four TLS groups [59] . Refinement statistics are given in Table 1 .
The quality of the final models was validated with MolProbity [35] . Crystal contact analysis was performed using the PISA server [36] . A structure similarity search of the Protein Data Bank was performed with the program Dali [38] . All figures showing structural representations were prepared with the program PyMOL [60] . Atomic coordinates and experimental structure factors have been deposited in the Protein Data Bank (PDB ID: 5OAR).
Identification of site-specific glycoforms of the propeptide
The propeptide was separated from the catalytic core by reversed-phase chromatography on a Vydac-C4 column (1 9 25 cm; Dionex, Sunnyvale, CA, USA). The column was equilibrated with mobile-phase solution A (0.1% trifluoroacetic acid in water), and the AoHEX sample was acidified prior to separation by adding trifluoroacertic acid to reach pH 2.5. The elution gradient of mobile-phase solution B (0.07% trifluoroacetic acid in 95% acetonitrile) in solution A at a flow rate of 1 mLÁmin À1 was as follows: 0-5 mL: 0%, 5-50 mL: 0-70%, 50-51 mL: 70-100%, 51-55 mL: 100%, 55-60 mL: 100-0%. The elution profile was monitored by measuring the absorbance at 280 nm. A 10 lg aliquot of isolated AoHEX propeptide was resuspended in 100 lL of 30% acetonitrile in water containing 1% acetic acid and directly infused into a Dual II electrospray ionization source (Bruker Daltonics, Billerica, MA, USA) by an external syringe pumping system (KDS Scientific, Holliston, MA, USA) with a flow rate of 180 lLÁh À1 . Mass spectra were acquired in positive ion mode on an APEX-Ultra FTMS instrument equipped with a 9.4 T superconducting magnet (Bruker Daltonics). ECD was performed with an indirectly heated hollow cathode operated at 1.9 A of heater current (Heatwave, Crescent Valley, BC, Canada). Mass spectra were obtained by accumulating ions in the collision hexapole and running the Q mass filter in nonmass-selective RF only mode. The precursor ions were selected within a 5 m/z window, and fragmentation was induced by (a) dropping the potential of the collision cell (CID) or (b) transferring the intact molecular ions to the analyzer cell and irradiating them with an electron beam (ECD). All MS and MS/MS spectra were acquired in the positive ion mode with 1 M data points and 128 time-domain transients. Typical conditions for fragmentation of the nine-fold charged glycoprotein include dropping the collision cell potential to À16.5 V for CID and pulsing the electron energy to a value of À3.5 V with an irradiation time of 100.0 ms for ECD (at all other times, the electron-emitting surface was biased to +15 V to prevent electrons from being emitted toward the analyzer cell). The instrument was externally calibrated using arginine cluster ions. The acquired spectra were apodized with a square sine bell function and Fourier transformed with one zero-fill. The obtained data were processed by DataAnalysis 4.0 (Bruker Daltonics) software and by LinX (http://pe terslab.org/MSTools/).
Mass spectrometric analysis of cross-linked protein and catalytic core glycopeptides MA, USA), using a microdialysis system (Pierce). The final concentration of the protein was 0.2 mgÁmL
À1
. EDC was dissolved in 50 mM pyridine-HCl, pH 6.5, immediately before use. EDC was added to the protein solution in a 50-or 100-fold molar excess over AoHEX. The optimal incubation conditions for the cross-linking reaction were 4 h at room temperature. Different forms of crosslinked AoHEX were separated by SDS/PAGE under reducing conditions. Bands corresponding to the AoHEX homodimer and propeptide-catalytic core complex were excised for in-gel digestion. The disulfide bonds were reduced with 50 mM tris(2-carboxyethyl)phosphine and alkylated with 50 mM iodoacetamide. In-gel proteolysis by Glu-C (Roche, Basel, Switzerland) or trypsin (Promega, Madison, WI, USA) was carried out overnight at 25°C or 37°C, respectively, with an enzyme : protein ratio of 1 : 20 (w : w). The peptide mixtures were desalted on a peptide MacroTrap column (Michrom Bioresources, Auburn, CA, USA) and dried with a SpeedVac vacuum concentrator. For LC-MS analysis, peptides were dissolved in 30 lL solvent A [0.2% (v/v) formic acid, 2.5% (v/v) acetonitrile, and 2.5% (v/v) isopropanol] and 1 lL was injected onto a MAGIC C18 column (0.2 9 150 mm; Michrom Bioresources) connected to an Apex-ULTRA Qe FT-ICR mass spectrometer (Bruker Daltonics) equipped with a 9.4 T superconducting magnet via a Dual II electrospray ion source. Peptides were eluted at a flow rate of 4 lLÁmin À1 under the following gradient conditions: 1-10% B in 1 min, 10-40% B in 29 min, and 40-95% B in 5 min. Solvent A was 0.2% (v/v) formic acid, 2.5% (v/v) acetonitrile, and 2.5% (v/v) isopropanol in water, and solvent B was 0.16% (v/v) formic acid in 90% (v/v) acetonitrile and 5% (v/v) isopropanol. The instrument was calibrated externally using arginine clusters. Data acquisition and data processing were performed using APEXCONTROL 3.0.0 and DATAANALYSIS 4.0 (Bruker Daltonics) software. The cross-linked peptides were identified using LinX software (http://peterslab.org/MSTools/). The LinX algorithm was set to consider possible single oxidation of methionine and carboxyamidomethylation of cysteines. The mass error threshold was set to 4 ppm, and all assigned fragments were verified manually.
Supporting information
Additional Supporting Information may be found online in the supporting information tab for this article: Table S1 . Mass spectrometry data of the AoHEX catalytic core digested by trypsin. Table S2 . A list of propeptide-core interactions.
